We recently compiled a list of the 10 Best Innovative Healthcare Stocks to Buy Now. United Therapeutics Corporation (NASDAQ:UTHR) is one of the best healthcare stocks on our list.
TheFly reported on June 29 that Leerink Partners characterized the FDA’s premarket approval of LungFX for UTHR as a positive development for the company and the broader transplantation sector. The firm stated that the approval marks another regulatory advancement supporting UTHR’ long-term organ manufacturing strategy. According to the analyst, the milestone further reinforces the company’s potential position in the development of centralized ex vivo lung perfusion technologies. Leerink maintains an Outperform rating on United Therapeutics shares.
In other news, on July 2, United Therapeutics Corporation (NASDAQ:UTHR) announced the acquisition of Thymmune Therapeutics, a privately held biotechnology company focused on developing regenerative thymic cell therapies for potential applications in transplant tolerance, immune disorders, and autoimmune conditions. Thymmune’s technology uses human-induced pluripotent stem cells to create thymic cells that may help restore functional T-cell activity after integration into the body. The company’s lead program, THY-100, is being developed for congenital athymia, a rare and severe disorder caused by the absence of a functioning thymus. United Therapeutics completed the acquisition for $140 million in cash, subject to adjustments, along with potential additional earn-out payments of up to $160 million tied to clinical and regulatory milestones through 2031.
United Therapeutics Corporation (NASDAQ:UTHR) is a biotechnology company focused on treating life-threatening diseases, including pulmonary arterial hypertension (PAH), while addressing the global organ shortage. Its portfolio includes FDA-approved PAH therapies such as Tyvaso, Remodulin, and Orenitram, along with innovations in xenotransplantation, 3D bioprinting, cellular regeneration, and ex vivo lung perfusion to advance organ transplantation.
While we acknowledge the risk and potential of UTHR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than UTHR and that has 10,000% upside potential, check out our report about this cheapest AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years
Disclosure: None. Follow Insider Monkey on Google News.
